Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8299 USD | -0.71% |
|
+7.31% | -74.23% |
Jul. 09 | Immunic Names President/COO, Chief Development Officer | MT |
Jul. 09 | Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 1.660 | 1.660 | 1.700 |
Spread/Res. | -50.01% | -50.01% | -51.18% |
Spread/Supp. | +18.56% | +18.56% | +11.32% |
Support | 0.7000 | 0.7000 | 0.7455 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- OVID Stock
- Charts Ovid Therapeutics Inc.